Microencapsulation and modification of synthetic peptides of food proteins reduces the blood pressure of spontaneously hypertensive rats

Journal of Agricultural and Food Chemistry

Volumn 51, Issue 6, 2003, Pages 1671-1675

  Chen, Tzy Li ^a   Lo, Yung Chieh ^a   Hu, Wei Tze ^a   Wu, Ming Chang ^b   Chen, Shui Ten ^c   Chang, Hung Min ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

Author keywords

Angiotensin converting enzyme inhibitor; Liposome; Modification; Oligopeptide; Spontaneously hypertensive rats (SHR)

Indexed keywords

ARGININE; DEXTRO PHENYLGLYCYLLEUCYLARGINYLPROLINE; GLYCINE; LEUCINE; LEUCYLLYSYLPROLINE; LIPOSOME; PROLINE; PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISULFIDE BOND; FOOD PROCESSING; HYPERTENSION; MALE; MICROENCAPSULATION; NONHUMAN; PROTEIN MODIFICATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; DIETARY PROTEINS; HYDROLYSIS; KINETICS; LIPOSOMES; PEPTIDES; PEPTIDES, CYCLIC; RATS; RATS, INBRED SHR; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0037433484     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf020900u     Document Type: Article

References (39)

1. Parker, F.; Migliore-Samour, O.; Floch, F.; Zerial, A.; Werner, G. H.; Jolles, J.; Casaretto, M.; Zahn, H.; Jolles, P. Immunostimulating hexapeptide from human case in amino acid sequence, synthesis and biological properties. Eur. J. Biochem. 1984, 145, 677-682.
2. Fiat, A. M.; Daniele, M. S.; Pierre, J. Biological active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. J. Dairy Sci. 1993, 76, 301-310.
3. Zioudrou, C.; Streaty, R. A.; Klee, W. A. Opioid peptides derived from food proteins. J. Biol. Chem. 1979, 254, 2446-2449.
4. Ramabadran, K.; Bansinath, M. Pharmacology of β-casomorphins, opioid peptides derived from milk protein. Asia Pac. J. Pharmacol. 1989, 4, 45-49.
5. Scarborough, R. H.; Rose, J. W.; Hsu, M. H.; Phillips, D. R.; Fried, V. A.; Campbell, A. M.; Manniaai, L.; Charo, I. F. Barbourin AGpIIb-IIIa specific integrin antagonist from the venom of sistrurus M, Barbouri. J. Biol. Chem. 1991, 266, 9359-9360.
6. Maubois, J. L.; Leonil, J. Peptides du lait a activite biologique. Lait 1989, 69, 245-269.
7. Fox, P. F.; Mulvihill, D. M. Developments in milk protein processing. Food Sci. Technol. Today 1993, 7, 152-161.
8. Bellamy, W. R.; Wakabayashi, H.; Takase, M.; Kawase, K.; Shimamura, S.; Tomita, M. Role of cell-binding in the antibacterial mechanism of Lactoferricin B. J. Appl. Bacteriol. 1993, 75, 478-484.
9. Ehlers, M. R.; Riordan, J. F. Angiotensin-converting enzyme new concepts converting its biological role. Biochemistry 1989, 28, 5311-5317.
10. Ariyoshi, Y. Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci. Technol. 1993, 4, 139-143.
11. Byers, L. D.; Wolfenden, R. Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A. Biochemistry 1973, 12, 1070-2078.
12. Cushman, D. W.; Cheung, H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 1971, 20, 1637-1648.
13. Studdy, P. R.; Lapworth, R.; Bird, R. Angiotension-converting enzyme and its clinical significance - a review. J. Clin. Pathol. 1983, 36, 938-947.
14. Salvetti, A. Newer ACE inhibitors. A look at the future. Drugs 1990, 40, 800-826.
15. Yamamoto, N. Antihypertensive peptides derived from food proteins. Biopolymers 1997, 43, 129-134.
16. Cheung, H. S.; Wang, F. L.; Ondetti, M. A.; Sabo, E. F.; Cushman, D. W. Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. J. Biol. Chem. 1980, 255, 401-407.
17. Kohmura, M.; Nio, N.; Kubo, K.; Minoshima, Y.; Munekata, E.; Ariyoshi, Y. Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human β-casein. Agric. Biol. Chem. 1989, 53, 2107-2114.
18. Kohmura, M.; Nio, N.; Ariyoshi, Y. Inhibition of angiotensinconverting enzyme by synthetic peptide fragments of human κ-casein. Agric. Biol. Chem. 1990, 54, 835-836.
19. Blackburn, C.; Pingali, A.; Kehoe, T.; Herman, H. W.; Kates, S. A. Libraries of angiotensin converting enzyme inhibitors: Solid-phase synthesis and affinity selection. Bioorg. Med. Chem. Lett. 1997, 7, 823-826.
20. Miyoshi, S.; Kaneko, T.; Yoskizawa, Y.; Fukui, F.; Tananka, H.; Maruyama, S. Hypertensive activity of enzymatic α-zein hydrolysate. Agric. Biol. Chem. 1991, 5, 1407-1408.
21. Matsumura, N.; Fujii, M.; Takeda, Y.; Shimizu, T. Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci. Biotech. Biochem. 1993, 57, 1743-1744.
22. Balassa, L. L.; Fanger, G. O. Microencapsulation in the food industry. CRC Crit. Rev. Food Technol. 1971, 7, 245-261.
23. Rosenberg, M.; Young, S. L. Whey proteins as microencapsulating agents. Microencapsulation of anhydrous milkfat-structure evaluation. Food Struct. 1993, 12, 31-41.
24. Koide, K.; Karel, M. Encapsulation and stimulated release of enzymes using lecithin vesicles. Int. J. Food Sci. Technol. 1987, 22, 707-723.
25. Chang, H. M.; Lee, Y. C.; Chen, C. C.; Tu, Y. Y. Microencapsulation protects immunoglobulin in yolk (IgY) specific against Helicobactor pylori urease. J. Food Sci. 2002, 67, 15-20.
26. Rustum, Y. M.; Dave, C.; Mayhew, E.; Papahadjopoulos, D. Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-β-D-arabinofuranosylcytosine against mouse L1210 leukemia. Cancer Res. 1979, 39, 1390-1395.
27. Gregoriadis, G. Liposome Technology; CRC Press: Boca Roton, FL, 1984; Vol. 3, pp 1-282.
28. Kikuchi, H.; Inoue, K. Liposomes: properties and applications. Yukagaku 1985, 34, 784-798.
29. Terada, S.; Kato, T.; Izumiya, N. Synthesis and hydrolysis by pepsin and trypsin of a cyclic hexapeptide containing lysin and phenylalanine. Eur. J. Biochem. 1975, 52, 273-282.
30. Wang, H. P.; Lu, H. H.; Lee, J. S.; Cheng, C. Y.; Mah, J. R.; Ku, C. Y.; Hsu, W.; Yen, C. F.; Lin, C. J.; Kuo, H. S. Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugs. J. Phann. Pharmacol. 1996, 48, 271-278.
31. Adler-Nissen, J. Control of the proteolytic reaction and of the level of bitterness in protein hydrolysis processes. J. Chem. Tech. Biotechnol. 1984, 34, 215-222.
32. Maruyama, S.; Suzuki, H. A peptide inhibitor of angiotensin I converting enzyme in the tryptic hydrolysate of casein. Agric. Biol. Chem. 1982, 46, 1393-1394.
33. Shimizu, M.; Miwa, Y.; Hashimoto, K.; Goto, A. Encapsulation of egg yolk immunoglobulin G (IgY) by liposomes. Biosci. Biotech. Biochem. 1993, 57, 1445-1449.
34. SAS Institute, Inc. SAS User's Guide. Statistics, Version 6.11; SAS Institute, Inc.: Cary, NC, 1995.
35. Fujita, H.; Yoshikawa, M. LKPM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 1999, 44, 123-127.
36. Maruyama, S.; Miyoshi, S.; Tanaka, H. Angiotensin I-converting enzyme inhibitors derived from Ficus carica. Agric. Biol. Chem. 1989, 53, 2763-2767.
37. Szoka, F. C.; Papahadjopoulos, D. Comparative properties and methods of preparation of lipid vesicle-liposomes. Annu. Rev. Biophys. Bioeng. 1978, 9, 467-508.
38. Hsieh, Y. F.; Chen, T. L.; Wang, Y. T.; Chang, J. H.; Chang, H. M. Properties of liposomes prepared with various lipids. J. Food Sci. 2002, 67, 2808-2813.
39. Suetsuna, K.; Osajima, K. Blood pressure reduction and vasodilatory effects in vivo of peptides originating from sardine muscle. Nihon Eiyo Shokuryo Gakkaishi 1989, 42, 47-54.